0001179110-18-010999.txt : 20180829 0001179110-18-010999.hdr.sgml : 20180829 20180829172038 ACCESSION NUMBER: 0001179110-18-010999 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180828 FILED AS OF DATE: 20180829 DATE AS OF CHANGE: 20180829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leamon Christopher P CENTRAL INDEX KEY: 0001509415 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35050 FILM NUMBER: 181044991 MAIL ADDRESS: STREET 1: 3000 KENT AVE STE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENDOCYTE INC CENTRAL INDEX KEY: 0001235007 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3000 KENT AVE STE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 BUSINESS PHONE: 7654637175 MAIL ADDRESS: STREET 1: 3000 KENT AVE STE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 4 1 edgar.xml FORM 4 - X0306 4 2018-08-28 0 0001235007 ENDOCYTE INC ECYT 0001509415 Leamon Christopher P 3000 KENT AVE, SUITE A1-100 WEST LAFAYETTE IN 47906 0 1 0 0 Vice President of Research Common Stock 2018-08-28 4 M 0 12670 2.54 A 143051 D Common Stock 2018-08-28 4 S 0 12670 20.0002 D 130381 D Common Stock 2018-08-29 4 M 0 4696 2.54 A 135077 D Common Stock 2018-08-29 4 S 0 4696 20.0000 D 130381 D Stock Option (right to buy) 2.54 2018-08-28 4 M 0 12670 0 D 2019-03-05 Common Stock 12670 24696 D Stock Option (right to buy) 2.54 2018-08-29 4 M 0 4696 0 D 2019-03-05 Common Stock 4696 20000 D The stock options were exercised pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934. Represents the sale of 12,670 shares in multiple transactions, ranging in price from $20.0000 to $20.0100, resulting in a weighted-average sale price per share of $20.0002. The reporting person will provide, upon request by SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range. The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934. The shares were sold pursuant to a written plan specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934. The option is fully vested and immediately exercisable. /s/ Michael A. Sherman, Attorney-in-Fact for Christopher P. Leamon (power of attorney previously filed) 2018-08-29